Comparison of mortality and outcomes of four respiratory viruses in the intensive care unit: a multicenter retrospective study

Baptiste Grangier,Charles-Hervé Vacheron,Donatien De Marignan,Jean-Sebastien Casalegno,Sandrine Couray-Targe,Audrey Bestion,Florence Ader,Jean-Christophe Richard,Emilie Frobert,Laurent Argaud,Thomas Rimmele,Anne-Claire Lukaszewicz,Frédéric Aubrun,Frédéric Dailler,Jean-Luc Fellahi,Julien Bohe,Vincent Piriou,Bernard Allaouchiche,Arnaud Friggeri,Florent Wallet,Fabrice Thiolliere,Emilie Joffredo,Lucille Jay,Marie Darien,Jean-Stéphane David,Charlotte Cerruti,Maxime Lecocq,Guillaume Izaute,Thomas Collenot,Olivia Vassal,The Lyon Sud COVID-19 ICU
DOI: https://doi.org/10.1038/s41598-024-55378-x
IF: 4.6
2024-03-21
Scientific Reports
Abstract:This retrospective study aimed to compare the mortality and burden of respiratory syncytial virus (RSV group), SARS-CoV-2 (COVID-19 group), non-H1N1 (Seasonal influenza group) and H1N1 influenza (H1N1 group) in adult patients admitted to intensive care unit (ICU) with respiratory failure. A total of 807 patients were included. Mortality was compared between the four following groups: RSV, COVID-19, seasonal influenza, and H1N1 groups. Patients in the RSV group had significantly more comorbidities than the other patients. At admission, patients in the COVID-19 group were significantly less severe than the others according to the simplified acute physiology score-2 (SAPS-II) and sepsis-related organ failure assessment (SOFA) scores. Using competing risk regression, COVID-19 (sHR = 1.61; 95% CI 1.10; 2.36) and H1N1 (sHR = 1.87; 95% CI 1.20; 2.93) were associated with a statistically significant higher mortality while seasonal influenza was not (sHR = 0.93; 95% CI 0.65; 1.31), when compared to RSV. Despite occurring in more severe patients, RSV and seasonal influenza group appear to be associated with a more favorable outcome than COVID-19 and H1N1 groups.
multidisciplinary sciences
What problem does this paper attempt to address?
This paper aims to compare the mortality and disease burden of four respiratory viruses (respiratory syncytial virus (RSV), SARS - CoV - 2 (COVID - 19), non - H1N1 seasonal influenza and H1N1 influenza) in adult patients in the intensive care unit (ICU). Specifically, through this multi - center retrospective study, the researchers hope to evaluate the 90 - day survival rate and other related clinical outcomes, such as ICU length of stay, ICU - related complications, organ support requirements and severity, etc., of these four viruses in adult patients with acute respiratory failure. The research background indicates that although respiratory syncytial virus (RSV) is well - known as the main pathogen of acute lower respiratory tract infections in the pediatric population, there is relatively little data in adults, especially in the ICU environment. In addition, the prevalence of acute respiratory failure caused by community - acquired respiratory viruses (CARVs) has long been underestimated, and it was not until the two pandemics (H1N1 and SARS - CoV - 2) in recent decades that people were once again reminded that respiratory viruses pose a significant threat to public health. Therefore, this study fills this knowledge gap in this field and provides a reference for clinical treatment by comparing the effects of different viruses.